Assessing the Impact of Clinical Decision Support Interventions

March 9, 2021 | Sean O'Neill

Dose Error Reduction Software (DERS) is designed to reduce medication safety events by providing limitations for how medications are to be used. Many hospitals have done the work to optimize and implement changes to their clinical decision support; however, most organizations don’t have visibility on the impact of those interventions. Access to and continuous surveillance of infusion pump data provides a unique opportunity for clinicians to understand the impact of their interventions on key performance metrics like alert burden, compliance to DERS, and more.

In this 20-minute webinar, Sean O’Neill, PharmD, Chief Clinical Officer at Bainbridge Health, reviews trends in impact data from 12 of our network hospitals. The talk highlights:

  • The impact of clinical interventions on dose max and dose min alerting for Dexmedetomidine, Propofol, Phenylephrine, and Opioid Continuous
  • Benchmarking data form our network to help drive better outcomes across hospitals nationwide

Please fill out the following form to access the webinar. We require this form to ensure there is no improper access to copyrighted materials. Thank you for your understanding!

Assessing the Impact of Clinical Decision Support Interventions

March 9, 2021 | Sean O'Neill

Dose Error Reduction Software (DERS) is designed to reduce medication safety events by providing limitations for how medications are to be used. Many hospitals have done the work to optimize and implement changes to their clinical decision support; however, most organizations don’t have visibility on the impact of those interventions. Access to and continuous surveillance of infusion pump data provides a unique opportunity for clinicians to understand the impact of their interventions on key performance metrics like alert burden, compliance to DERS, and more.

In this 20-minute webinar, Sean O’Neill, PharmD, Chief Clinical Officer at Bainbridge Health, reviews trends in impact data from 12 of our network hospitals. The talk highlights:

  • The impact of clinical interventions on dose max and dose min alerting for Dexmedetomidine, Propofol, Phenylephrine, and Opioid Continuous
  • Benchmarking data form our network to help drive better outcomes across hospitals nationwide